Pharmaceutical Spain’s largest drugmaker, Almirall (ALM: MC), announced at the end of last year the acquisition of Aqua Pharmaceuticals, a privately-held company based in the USA and focused mainly on acquiring, developing and marketing branded prescription dermatology products (The Pharma Letter December 17, 2013). TPL’s Spain correspondent now takes a deeper look into the company. 3 April 2014